AbbVie Inc. and Google-backed Calico Life Sciences LLC will each add another $500 million into a research collaboration looking for new treatments for age-related diseases such as neurodegeneration and cancer.
Calico and AbbVie Add $1 Billion to Anti-Aging Joint Venture
